Monitoring democratic institutions through public records
executiveActions
The rate and scope of executive orders, memoranda, and rulemaking serve as a structural indicator of executive assertiveness. Abnormal volume spikes — especially paired with procedural shortcuts like interim final rules — can signal an effort to entrench policy before institutional pushback materializes.
Executive orders carry out laws; when they replace laws, policy lasts exactly until the next president’s pen. Why this matters →
Know of a government action in this category that we missed? Tell us.View the AI prompts used to assess this category
AI content assessment elevated
Document review shows a sustained, high rate of clear-departure documents. Warrants close examination of the underlying record.
The week of April 20, 2026, saw a coordinated burst of presidential determinations invoking the Defense Production Act (DPA) to direct federal resources toward fossil fuel and energy infrastructure while bypassing the Act's own procedural safeguards. Five determinations published on April 23 each invoked Section 303(a)(7)—which permits the president to waive the procedural requirements of Sections 303(a)(1) through (a)(6)—thereby bypassing provisions Congress established to require feasibility studies, cost-effectiveness analyses, and congressional notification before the executive commits federal funds to industrial capacity expansion. The determinations covered coal supply chains, large-scale energy infrastructure, grid equipment, petroleum production and refining, and natural gas and LNG capacity. All five rest on the same January 2025 national energy emergency declaration (EO 14156).
This pattern may matter because the DPA's internal procedural requirements—particularly congressional notification and economic analysis—function as a check on unilateral executive spending authority over industrial policy. Their simultaneous waiver across five energy sectors could erode Congress's statutory oversight role in how federal funds are committed to private industry, potentially shifting significant economic decision-making toward the executive branch without the deliberative process Congress intended when it wrote these safeguards into law.
The most plausible benign reading is that DPA Section 303(a)(7) waivers are an established legal mechanism; the Biden administration used identical authority in 2022 for heat pumps and critical minerals, and the Trump first term invoked similar powers for COVID-19 medical supplies. The statutory authority exists precisely for situations the president deems urgent. Second, some of the covered sectors—grid transformers, petroleum logistics—face genuine supply chain constraints documented by DOE and industry analyses, meaning the underlying policy rationale is not fabricated. Third, the waivers do not eliminate all oversight; congressional appropriations still control actual funding, and judicial review remains available. Fourth, the administration may view these waivers as temporary, time-sensitive measures responding to what it characterizes as an ongoing national energy emergency requiring rapid mobilization. However, what distinguishes this week's actions is their breadth and simultaneity: five determinations covering virtually the entire fossil fuel value chain plus general "large-scale energy infrastructure" issued on a single day, all waiving all six procedural subsections. The LNG determination notably extends the national defense rationale to "allied energy security," stretching the DPA's traditional scope. The cumulative effect may create executive discretion over energy industrial policy that could substantially reduce the checks the Act's own safeguards were designed to provide.
Beyond the DPA determinations, a presidential proclamation imposing Section 232 tariffs on pharmaceutical imports applies national security trade authority to a sector traditionally governed by FDA regulation and standard trade law, further extending the pattern of reframing domestic policy as national security to access expedited executive authorities. An executive order on psychedelic drug approvals directs accelerated rescheduling and Right to Try pathways that could compress multi-stakeholder review processes, though its practical impact depends on implementation.
Separately, a Congressional Black Caucus floor speech on Black maternal health detailed executive actions that constitute operational hollowing of federal health infrastructure: mass HHS layoffs eliminating maternal mortality research capacity, elimination of DEI-linked hospital accountability mechanisms, and proposed FY2027 budget cuts exceeding $800 million to maternal and child health programs including complete elimination of Healthy Start and maternal mortality review committees. While this is a single legislator's characterization, the specific programs named are verifiable through budget documents.
Limitations: This analysis relies on AI-assisted review of published documents and cannot assess implementation, legal challenges in progress, or internal executive branch deliberations. The floor speech on maternal health reflects one member's framing and has not been independently verified against all cited budget figures. DPA waiver authority has legal precedent, and whether its use here exceeds established norms is a matter of legal interpretation on which reasonable analysts may disagree.